New patent expiration for Fresenius Kabi drug NAROPIN
Annual Drug Patent Expirations for NAROPIN Naropin is a drug marketed by Fresenius Kabi Usa and is included in one […]
New patent expiration for Fresenius Kabi drug NAROPIN Read Post »
Patent Expiration
New patent expiration for NOVO drug OZEMPIC
Annual Drug Patent Expirations for OZEMPIC Ozempic is a drug marketed by Novo and is included in one NDA. It
New patent expiration for Merck Sharp drug PREVYMIS
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
New patent expiration for Merck Sharp drug PREVYMIS Read Post »
New patent expiration for Ge Healthcare drug VIZAMYL
Annual Drug Patent Expirations for VIZAMYL Vizamyl is a drug marketed by Ge Healthcare and is included in one NDA.
New patent expiration for Ge Healthcare drug VIZAMYL Read Post »
New patent expiration for Alexza Pharms drug ADASUVE
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA.
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
New patent expiration for Alexza Pharms drug ADASUVE
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA.
New patent expiration for Alexza Pharms drug ADASUVE Read Post »
Drug Patent Expirations for the Week of May 19, 2024
ADASUVE (loxapine) Alexza pharms Patent: 9,370,629 Expiration: May 20, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of May 19, 2024 Read Post »
New patent expiration for Validus Pharms drug EQUETRO
Annual Drug Patent Expirations for EQUETRO Equetro is a drug marketed by Validus Pharms and is included in one NDA.
New patent expiration for Validus Pharms drug EQUETRO Read Post »
New patent expiration for Shionogi Inc drug ULESFIA
Annual Drug Patent Expirations for ULESFIA Ulesfia is a drug marketed by Shionogi Inc and is included in one NDA.
New patent expiration for Shionogi Inc drug ULESFIA Read Post »
